HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryan Limbocker Selected Research

Proteins (Proteins, Gene)

2/2024Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.
2/2023EGCG inactivates a pore-forming toxin by promoting its oligomerization and decreasing its solvent-exposed hydrophobicity.
1/2023Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
1/2021Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers.
11/2020Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers.
1/2020Rational design of a conformation-specific antibody for the quantification of Aβ oligomers.
1/2020A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease.
1/2020Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryan Limbocker Research Topics

Disease

11Alzheimer Disease (Alzheimer's Disease)
02/2024 - 10/2017
6Neurodegenerative Diseases (Neurodegenerative Disease)
02/2023 - 11/2020
5Parkinson Disease (Parkinson's Disease)
01/2023 - 01/2017
3Neuroblastoma
02/2024 - 01/2017
3Proteostasis Deficiencies
02/2024 - 01/2020
3Amyloid Plaque
01/2023 - 01/2020
2Paralysis (Palsy)
01/2018 - 01/2017
1Synucleinopathies
01/2023
1Nervous System Diseases (Neurological Disorders)
01/2021

Drug/Important Bio-Agent (IBA)

11Amyloid (Amyloid Fibrils)IBA
02/2024 - 10/2017
8Peptides (Polypeptides)IBA
02/2024 - 10/2017
8Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2020
5SynucleinsIBA
01/2023 - 01/2017
324-dihydroxy-5-cholestane 24-sulfate 3-N-1(spermine)-7IBA
01/2022 - 01/2018
2squalamineIBA
01/2022 - 01/2017
1MetalsIBA
02/2024
1IonsIBA
02/2024
1SolventsIBA
02/2023
1Amyloidogenic ProteinsIBA
01/2023
1Intrinsically Disordered ProteinsIBA
01/2018
1LipidsIBA
01/2017